# Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer

> **NCT00287963** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 18 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** topotecan hydrochloride
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00287963
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287963, "Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00287963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*